Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Waegemans

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Topics in Microbiology and Immunology|June 14, 2012
Notch signaling during human T cell developmentTom Taghon, Els Waegemans, Inge Van de Walle
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancerLiesbet Vervoort, Ingrid Burvenich, Steven Staelens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
Notch3 activation is sufficient but not required for inducing human T-lineage specificationEls Waegemans, Inge Van de Walle, Jelle De Medts, et al.
Blood|March 5, 2011
Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisionsInge Van de Walle, Greet De Smet, Martina Gärtner, et al.
The Journal of Experimental Medicine|March 27, 2013
Specific Notch receptor-ligand interactions control human TCR-αβ/γδ development by inducing differential Notch signal strengthInge Van de Walle, Els Waegemans, Jelle De Medts, et al.
Nature Communications|April 7, 2016
GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fateInge Van de Walle, Anne-Catherine Dolens, Kaat Durinck, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Topics in Microbiology and Immunology|June 14, 2012
Notch signaling during human T cell developmentTom Taghon, Els Waegemans, Inge Van de Walle
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancerLiesbet Vervoort, Ingrid Burvenich, Steven Staelens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
Notch3 activation is sufficient but not required for inducing human T-lineage specificationEls Waegemans, Inge Van de Walle, Jelle De Medts, et al.
Blood|March 5, 2011
Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisionsInge Van de Walle, Greet De Smet, Martina Gärtner, et al.
The Journal of Experimental Medicine|March 27, 2013
Specific Notch receptor-ligand interactions control human TCR-αβ/γδ development by inducing differential Notch signal strengthInge Van de Walle, Els Waegemans, Jelle De Medts, et al.
Nature Communications|April 7, 2016
GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fateInge Van de Walle, Anne-Catherine Dolens, Kaat Durinck, et al.
Pageof 1